WallStreetZenWallStreetZen

NASDAQ: DNLI
Denali Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Denali Therapeutics revenue was $0.00 for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DNLI annual revenue was $0.0, with -100% growth year-over-year.

DNLI past revenue growth

How has DNLI's revenue growth performed historically?

Company
-100%
Industry
152.2%
Market
20.01%
DNLI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DNLI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DNLI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DNLI revenue history

Current Revenue
$0.0
Current Earnings
-$479.0M
Current Profit Margin
0%

Be the first to know when DNLI announces revenue.

DNLI Revenue History By Year

DNLI Yearly RevenueDNLI RevenueDNLI ChangeDNLI Revenue Growth
2024-12-31$0.00-$330.53M-100.00%
2023-12-31$330.53M$222.07M+204.74%
2022-12-31$108.46M$59.80M+122.90%
2021-12-31$48.66M-$287.00M-85.50%
2020-12-31$335.66M$308.98M+1,158.19%
2019-12-31$26.68M-$102.48M-79.34%
2018-12-31$129.16MN/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A

1 of 1

Denali Therapeutics Revenue FAQ

What was DNLI's revenue last quarter?

On Invalid Date, Denali Therapeutics (NASDAQ: DNLI) reported Q2 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Denali Therapeutics's revenue was $0.00.

What was Denali Therapeutics's revenue in 2024?

Denali Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.

How much does Denali Therapeutics make in a day?

Based on Denali Therapeutics annual revenue for the past five years, DNLI makes an average of $451,130.96 per day.

What was Denali Therapeutics's annual revenue growth in the past year?

As of Q4 2025, Denali Therapeutics's revenue has grown -100% year over year. This is 252.2 percentage points lower than the US Biotechnology industry revenue growth rate of 152.2%. Denali Therapeutics's revenue in the past year totaled $0.00.

How much does Denali Therapeutics make in a year?

Denali Therapeutics's revenue by year for the past five years is:
  • Denali Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
  • Denali Therapeutics's annual revenue for Dec 31, 2023 was $330.53 million, a 204.74% increase from 2022.
  • Denali Therapeutics's annual revenue for 2022 was $108.46 million, a 122.9% increase from 2021.
  • Denali Therapeutics's annual revenue for 2021 was $48.66 million, a 85.5% decrease from 2020.
  • Denali Therapeutics's annual revenue for 2020 was $335.66 million, a 1,158.19% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.